 |
市場調查報告書
商品編碼
1685163
兒茶素市場機會、成長動力、產業趨勢分析與 2025 - 2034 年預測Catechin Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034 |
||||||
2024 年全球兒茶素市場價值為 183 億美元，預計 2025 年至 2034 年期間將以 4.5% 的健康複合年成長率成長。這一擴張主要是由於消費者對天然抗氧化劑和有益於整體健康的化合物的偏好日益成長。兒茶素主要來自綠茶，因其在心血管健康、新陳代謝支持和消炎等方面的益處而廣受歡迎。隨著越來越多的消費者尋求預防性保健解決方案以及對功能性食品、膳食補充劑和護膚產品的需求不斷成長，兒茶素在健康和保健領域的地位得到鞏固。此外，其在製藥、食品飲料和個人護理等行業的日益廣泛的應用預計將在未來幾年進一步刺激需求。
隨著越來越多的人開始追求更健康的生活方式並意識到抗氧化劑的價值，兒茶素市場將大幅成長。人們明顯轉向以植物為基礎的成分和天然的、有科學依據的健康解決方案，這進一步支持了兒茶素在消費品中的作用不斷擴大。從膳食補充劑到護膚品，兒茶素被廣泛採用，是因為它們能夠解決肥胖、糖尿病和壓力相關疾病等現代健康問題。兒茶素除了對心血管和代謝有益外，現在還被視為任何想要增強免疫系統和抗發炎的人的必需成分。
| 市場範圍 | |
|---|---|
| 起始年份 | 2024 |
| 預測年份 | 2025-2034 |
| 起始值 | 183億美元 |
| 預測值 | 281億美元 |
| 複合年成長率 | 4.5％ |
根據類型，兒茶素市場分為表兒茶素、表兒茶素沒食子酸酯 (ECG)、表沒食子兒茶素 (EGC)、表沒食子兒茶素沒食子酸酯 (EGCG) 等。表兒茶素憑藉其獨特的健康益處和多樣化的應用，在 2024 年佔據市場主導地位，創造 70 億美元的收入。
兒茶素的來源主要有綠茶、可可、葡萄和其他植物成分。綠茶佔據最大的市場佔有率，到 2024 年將佔據 52.1% 的收入。這種主導地位歸因於綠茶的高抗氧化劑含量以及促進心臟健康、增強新陳代謝和幫助控制體重的良好聲譽。
在美國，兒茶素市場在 2024 年的產值達到 52 億美元。這一成長得益於消費者對健康和保健意識的不斷增強，以及對天然功能性成分的需求激增。肥胖、心血管疾病和糖尿病等健康問題正在推動食品、飲料和營養保健品領域富含兒茶素的產品的增加。隨著營養保健食品產業的擴張，向預防性醫療保健的轉變為兒茶素在旨在改善整體健康的產品中的應用創造了更多機會。
目錄
第 1 章：方法論與範圍
- 市場範圍和定義
- 基礎估算與計算
- 預測計算
- 資料來源
- 基本的
- 次要
- 付費來源
- 公共資源
第 2 章：執行摘要
第 3 章：產業洞察
- 產業生態系統分析
- 影響價值鏈的因素
- 利潤率分析
- 中斷
- 未來展望
- 製造商
- 經銷商
- 供應商概況
- 利潤率分析
- 重要新聞及舉措
- 監管格局
- 衝擊力
- 成長動力
- 注重健康的消費者
- 對天然成分的需求不斷成長
- 擴充應用
- 產業陷阱與挑戰
- 生產成本高
- 原料供應有限
- 成長動力
- 成長潛力分析
- 波特的分析
- PESTEL 分析
第4章：競爭格局
- 介紹
- 公司市佔率分析
- 競爭定位矩陣
- 戰略展望矩陣
第 5 章：市場估計與預測：按類型，2021 年至 2034 年
- 主要趨勢
- 表兒茶素
- 表兒茶素沒食子酸酯 (ECG)
- 表沒食子兒茶素 (EGC)
- 表沒食子兒茶素沒食子酸酯 (EGCG)
- 其他
第6章：市場估計與預測：依來源，2021-2034 年
- 主要趨勢
- 綠茶兒茶素
- 可可兒茶素
- 葡萄兒茶素
- 其他
第 7 章：市場估計與預測：按功能，2021 年至 2034 年
- 主要趨勢
- 抗氧化劑
- 心血管健康
- 體重管理
- 皮膚健康
- 消炎劑
- 大腦健康
- 其他
第 8 章：市場估計與預測：按應用，2021 年至 2034 年
- 主要趨勢
- 功能性食品
- 功能性飲料
- 化妝品和護膚品
- 營養保健品
- 其他
第 9 章：市場估計與預測：按地區，2021 年至 2034 年
- 主要趨勢
- 北美洲
- 美國
- 加拿大
- 歐洲
- 英國
- 德國
- 法國
- 義大利
- 西班牙
- 俄羅斯
- 亞太地區
- 中國
- 印度
- 日本
- 韓國
- 澳洲
- 拉丁美洲
- 巴西
- 墨西哥
- 中東及非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
第10章：公司簡介
- INDOFINE Chemical Company
- Botaniex
- Vital-Chem
- Caymanchem
- Biosynth
- Taiyo
- Hangzhou Qinyuan natural plant technology
- Novanat Bioresources
- Tata Chemicals Limited
- Indena
The Global Catechin Market, valued at USD 18.3 billion in 2024, is projected to grow at a healthy CAGR of 4.5% from 2025 to 2034. This expansion is largely driven by a growing consumer preference for natural antioxidants and compounds that promote overall health. Catechins, primarily sourced from green tea, are gaining widespread popularity for their proven benefits in areas such as cardiovascular health, metabolism support, and inflammation reduction. With more consumers seeking preventive healthcare solutions and the growing demand for functional foods, dietary supplements, and skincare products, catechins have solidified their place in the health and wellness sector. Additionally, their increasing use across industries like pharmaceuticals, food and beverages, and personal care is expected to further boost demand over the coming years.
As more people turn to healthier lifestyles and become aware of the value of antioxidants, the catechin market is set for substantial growth. There is a noticeable shift toward plant-based ingredients and natural, science-backed health solutions, which further supports catechins' expanding role in consumer products. The adoption of catechins in various forms, from dietary supplements to skincare, is driven by their ability to address modern health concerns such as obesity, diabetes, and stress-related conditions. Alongside their cardiovascular and metabolic benefits, catechins are now seen as an essential ingredient for anyone looking to boost their immune system and fight inflammation.
| Market Scope | |
|---|---|
| Start Year | 2024 |
| Forecast Year | 2025-2034 |
| Start Value | $18.3 Billion |
| Forecast Value | $28.1 Billion |
| CAGR | 4.5% |
By type, the catechin market is segmented into epicatechin, epicatechin gallate (ECG), epigallocatechin (EGC), epigallocatechin gallate (EGCG), and others. Epicatechin led the market in 2024, generating USD 7 billion in revenue thanks to its unique health benefits and diverse applications.
The sources of catechins are primarily green tea, cocoa, grapes, and other plant-based ingredients. Green tea holds the largest market share, capturing 52.1% of the revenue in 2024. This dominance is attributed to green tea's high antioxidant content and established reputation for promoting heart health, enhancing metabolism, and assisting in weight management.
In the U.S., the catechin market generated USD 5.2 billion in 2024. This growth is fueled by increasing consumer awareness of health and wellness, along with a surge in demand for natural, functional ingredients. Health concerns like obesity, cardiovascular diseases, and diabetes are driving the rise in catechin-enriched products across the food, beverage, and nutraceutical sectors. As the nutraceuticals industry expands, the shift toward preventive healthcare has created more opportunities for catechins in products aimed at improving overall well-being.
Table of Contents
Chapter 1 Methodology & Scope
- 1.1 Market scope & definitions
- 1.2 Base estimates & calculations
- 1.3 Forecast calculations
- 1.4 Data sources
- 1.4.1 Primary
- 1.4.2 Secondary
- 1.4.2.1 Paid sources
- 1.4.2.2 Public sources
Chapter 2 Executive Summary
- 2.1 Industry synopsis, 2021-2034
Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.1.1 Factor affecting the value chain
- 3.1.2 Profit margin analysis
- 3.1.3 Disruptions
- 3.1.4 Future outlook
- 3.1.5 Manufacturers
- 3.1.6 Distributors
- 3.2 Supplier landscape
- 3.3 Profit margin analysis
- 3.4 Key news & initiatives
- 3.5 Regulatory landscape
- 3.6 Impact forces
- 3.6.1 Growth drivers
- 3.6.1.1 Health-conscious consumers
- 3.6.1.2 Rising demand for natural ingredients
- 3.6.1.3 Expanding applications
- 3.6.2 Industry pitfalls & challenges
- 3.6.2.1 High production costs
- 3.6.2.2 Limited availability of raw materials
- 3.6.1 Growth drivers
- 3.7 Growth potential analysis
- 3.8 Porter’s analysis
- 3.9 PESTEL analysis
Chapter 4 Competitive Landscape, 2024
- 4.1 Introduction
- 4.2 Company market share analysis
- 4.3 Competitive positioning matrix
- 4.4 Strategic outlook matrix
Chapter 5 Market Estimates & Forecast, By Type, 2021-2034 (USD Billion) (Kilo Tons)
- 5.1 Key trends
- 5.2 Epicatechin
- 5.3 Epicatechin gallate (ECG)
- 5.4 Epigallocatechin (EGC)
- 5.5 Epigallocatechin gallate (EGCG)
- 5.6 Others
Chapter 6 Market Estimates & Forecast, By Source, 2021-2034 (USD Billion) (Kilo Tons)
- 6.1 Key trends
- 6.2 Green tea catechins
- 6.3 Cocoa catechins
- 6.4 Grape catechins
- 6.5 Others
Chapter 7 Market Estimates & Forecast, By Function, 2021-2034 (USD Billion) (Kilo Tons)
- 7.1 Key trends
- 7.2 Antioxidants
- 7.3 Cardiovascular health
- 7.4 Weight management
- 7.5 Skin health
- 7.6 Anti-inflammatory
- 7.7 Brain health
- 7.8 Others
Chapter 8 Market Estimates & Forecast, By Application, 2021-2034 (USD Billion) (Kilo Tons)
- 8.1 Key trends
- 8.2 Functional foods
- 8.3 Functional beverages
- 8.4 Cosmetics and skincare
- 8.5 Nutraceuticals
- 8.6 Others
Chapter 9 Market Estimates & Forecast, By Region, 2021-2034 (USD Billion) (Kilo Tons)
- 9.1 Key trends
- 9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
- 9.3 Europe
- 9.3.1 UK
- 9.3.2 Germany
- 9.3.3 France
- 9.3.4 Italy
- 9.3.5 Spain
- 9.3.6 Russia
- 9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 India
- 9.4.3 Japan
- 9.4.4 South Korea
- 9.4.5 Australia
- 9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.6 MEA
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 UAE
Chapter 10 Company Profiles
- 10.1 INDOFINE Chemical Company
- 10.2 Botaniex
- 10.3 Vital-Chem
- 10.4 Caymanchem
- 10.5 Biosynth
- 10.6 Taiyo
- 10.7 Hangzhou Qinyuan natural plant technology
- 10.8 Novanat Bioresources
- 10.9 Tata Chemicals Limited
- 10.10 Indena
